Prediction of human intestinal absorption of drug compounds from molecular structure

被引:298
作者
Wessel, MD
Jurs, PC
Tolan, JW
Muskal, SM [1 ]
机构
[1] Penn State Univ, Dept Chem, Davey Lab 152, University Pk, PA 16802 USA
[2] Affymax Res Inst, Santa Clara, CA 95051 USA
来源
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES | 1998年 / 38卷 / 04期
关键词
D O I
10.1021/ci980029a
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The absorption of a drug compound through the human intestinal cell lining is an important property for potential drug candidates. Measuring this property, however, can be costly and time-consuming. The use of quantitative structure-property relationships (QSPRs) to estimate percent human intestinal absorption (%HIA) is an attractive alternative to experimental measurements. A data set of 86 drug and drug-like compounds with measured values of %HIA taken from the literature was used to develop and test a QSPR model. The compounds were encoded with calculated molecular structure descriptors. A nonlinear computational neural network model was developed by using the genetic algorithm with a neural network fitness evaluator. The calculated %HIA (cHIA) model performs well, with root-mean-square (rms) errors of 9.4%HIA units for the training set, 19.7%HIA units for the cross-validation (CV) set, and 16.0%HIA units for the external prediction set.
引用
收藏
页码:726 / 735
页数:10
相关论文
共 174 条
[1]   HYDROGEN-BONDING .33. FACTORS THAT INFLUENCE THE DISTRIBUTION OF SOLUTES BETWEEN BLOOD AND BRAIN [J].
ABRAHAM, MH ;
CHADHA, HS ;
MITCHELL, RC .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (09) :1257-1268
[2]   Clinical pharmacokinetics of zidovudine - An update [J].
Acosta, EP ;
Page, LM ;
Fletcher, CV .
CLINICAL PHARMACOKINETICS, 1996, 30 (04) :251-262
[3]   CLINICAL PHARMACOKINETICS OF CHLORAMPHENICOL AND CHLORAMPHENICOL SUCCINATE [J].
AMBROSE, PJ .
CLINICAL PHARMACOKINETICS, 1984, 9 (03) :222-238
[4]   ESTIMATING HUMAN ORAL FRACTION DOSE ABSORBED - A CORRELATION USING RAT INTESTINAL-MEMBRANE PERMEABILITY FOR PASSIVE AND CARRIER-MEDIATED COMPOUNDS [J].
AMIDON, GL ;
SINKO, PJ ;
FLEISHER, D .
PHARMACEUTICAL RESEARCH, 1988, 5 (10) :651-654
[5]   APPLICATIONS OF NEURAL NETWORKS IN QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS OF DIHYDROFOLATE-REDUCTASE INHIBITORS [J].
ANDREA, TA ;
KALAYEH, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (09) :2824-2836
[6]   PREDICTION OF C-13 NUCLEAR-MAGNETIC-RESONANCE CHEMICAL-SHIFTS BY ARTIFICIAL NEURAL NETWORKS [J].
ANKER, LS ;
JURS, PC .
ANALYTICAL CHEMISTRY, 1992, 64 (10) :1157-1164
[7]  
ANTTILA M, 1976, ACTA PHARMACOL TOX, V39, P118
[8]   LISINOPRIL - A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR [J].
ARMAYOR, GM ;
LOPEZ, LM .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1988, 22 (05) :365-372
[9]   CORRELATION BETWEEN ORAL-DRUG ABSORPTION IN HUMANS AND APPARENT DRUG PERMEABILITY COEFFICIENTS IN HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS [J].
ARTURSSON, P ;
KARLSSON, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 175 (03) :880-885
[10]  
ARTURSSON P, 1991, CRIT REV THER DRUG, V8, P305